Abstract:A novel oligonucleotide probe was designed, characterized and utilized to study the distribution and modulation of the mRNA encoding the D2 dopamine receptor in the brain of the mouse. Using in situ hybridization histochemistry, the highest levels of the D2 receptor mRNA were found in regions of the brain containing the cell bodies and the terminal projection fields of the nigrostriatal, mesolimbic and mesocortical dopaminergic systems. Particularly high levels of the D2 receptor mRNA were found in substantia nigra pars compacta, ventral tegmental area, caudate-putamen and olfactory tubercle. This distribution generally paralleled that of the D2 dopamine receptor. Some areas, not usually associated with dopaminergic systems, also contained significant levels of the D2 receptor mRNA signal. These areas included the hippocampus, certain thalamic nuclei, the inferior colliculus and the spinal trigeminal nucleus of the medulla and spinal cord. Lesioning the corpus striatum with 6-hydroxydopamine had little effect on the level of the D2 receptor mRNA in the striatum but greatly reduced the hybridization signal in the substantia nigra pars compacta and ventral tegmental area. Similarly, lesioning the substantia nigra, nearly abolished the signal in the pars compacta but failed to substantially alter the D2 receptor mRNA signal in the striatum. These results suggest that the D2 receptor mRNA in the substantia nigra pars compacta was localized largely to dopaminergic cell bodies, the terminal projections of which lie in the striatum and codes for D2 autoreceptors and that the D2 receptor mRNA of the striatum is in non-dopaminergic cell bodies that are intrinsic to the striatum and probably codes for post-synaptic D2 receptors. Further, the evidence that lesions of striatum and substantia nigra induced with 6-hydroxydopamine greatly reduced the D2 receptor mRNA signal in the substantia nigra, without concomitantly increasing the D2 receptor mRNA in the striatum, suggests that the increase in dopamine receptor binding in the striatum that is ipsilateral to the lesion with 6-hydroxydopamine and the enhanced behavioral sensitivity to dopaminergic agonists, cannot be accounted for solely by an increase in D2 receptor mRNA.

The Activity Change of Dopamine D2 Receptors in Caudal-Putamen of Parkinsons Disease Model Rats

Autoradiographic Study of the Activity of Dopamine D2 Receptor in the Hemiparkinsonian Rat Model

Effects of Different Doses of L -Dopa on Rotational Behavior and Amounts of Cells Expressing D2 Receptors in Hemiparkinsonian Rats

Different Treatment Methods on Dynamic Changes of D_2 Receptors in Parkinson's Disease Rats in PD Rats

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Alterations in 5-HT<sub>2A</sub>receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

Neuronal activity and expression of 5-HT1A receptor of medial prefrontal cortex in rats model with parkinson's disease

Expression Pattern of Cannabinoid Receptor 1 in the Basal Ganglia of Parkinson's Disease Rat Model

Alterations of NMDA Receptor Binding in Various Brain Regions among 6-Hydroxydopamine-induced Parkinsonian Rats

The Altered Expression of M_2 Muscarinic Receptor in the Neurons of the Pedunculopontine Nucleus in 6-Hydrodopamine Unilaterally Lesioned Rats and Its Significance

Studies on Reaction of Spinal D1 and D2 Receptor Positive Neurons after 6-OHDA Lesion in Rats

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Nmda Receptor Regulation of Levodopa-Induced Behavior and Changes in Striatal G Protein-Coupled Receptor Kinase 6 and Beta-Arrestin-1 Expression in Parkinsonian Rats

Neuronal Activity Changes of the Laterodorsal Tegmental Nucleus in a Rodent Model of Parkinson's Disease

Differential effects of activating D1 and D2 receptors on electrophysiology of neostriatal neurons in a rat model of Parkinson's disease induced by paraquat and maneb.

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

Changes of neuronal activity of ventromedial prefrontal cortex in the rat model of Parkinson's disease

Neuronal Localization and Modulation of the D2 Dopamine Receptor Mrna in Brain of Normal Mice and Mice Lesioned with 6-Hydroxydopamine

Changes in the Firing Activity of Serotonergic Neurons in the Dorsal Raphe Nucleus in a Rat Model of Parkinson's Disease.